This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lewis Wexler, MD; Robert Ginsburg, MD; R. Scott Mitchell, MD; John Thomas Mehigan, MD

JAMA. 1989;261(3):418-419.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VASCULAR interventionalists owe much to the pioneering work of the recently deceased radiologists Charles Dotter and Melvin Judkins, who introduced the concept of percutaneous transluminal dilation of vascular obstructions.¹ This concept was accepted more readily in Europe than in the United States and was significantly advanced by a young German cardiologist working in Switzerland, Andreas Gruntzig. Originally trained as an angiologist, Gruntzig studied radiology and cardiology to apply his ideas for treating vascular obstructions to the coronary arteries. He designed, developed, and tested balloon catheters for the percutaneous transluminal relief of hemodynamically significant vascular lesions, first in peripheral vessels and later in the renal and coronary arteries.^2-4 The restraint he practiced and the scientific integrity he preached during the introductory phases of this potentially revolutionary technique are behavior patterns that, unfortunately, did not survive as a legacy after his untimely death. His procedure of percutaneous transluminal balloon angioplasty . . . [Full Text PDF of this Article]

Author Affiliations
From the Center for Interventional Vascular Therapies, Stanford University Medical Center, Stanford, Calif.

Footnotes
Reprint requests to Diagnostic Radiology, Stanford University Medical Center, Room P2033, Stanford, CA94305 (Dr Wexler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?